Related Experiment Video

Updated: Jul 10, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

[Stratification of global cardiovascular risk according to the ESH/ESC guidelines]

Bernard Waeber1, François Feihl

  • 1Division de physiopathologie, Dèpartement de médecine interne, CHUV et Université de Lausanne, 1011 Lausanne. Bernard.Waeber@chuv.ch

Revue Medicale Suisse
|October 25, 2007
PubMed

Insights

Cardiovascular risk varies in hypertensive patients based on additional risk factors like metabolic syndrome or diabetes. Assessing global cardiovascular risk helps identify patients who benefit most from lifestyle changes and blood pressure medication.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Risk Factor Assessment

Context:

  • Cardiovascular risk assessment is crucial for hypertensive patients.
  • Individual risk varies significantly despite similar blood pressure levels.
  • Co-existing conditions like metabolic syndrome, diabetes, and organ damage influence risk.

Purpose:

  • To highlight the importance of considering multiple risk factors in hypertension.
  • To emphasize that blood pressure alone does not fully determine cardiovascular risk.
  • To guide clinical decision-making in managing hypertensive individuals.

Summary:

  • Cardiovascular risk in hypertension is multifactorial, influenced by metabolic syndrome, diabetes, target organ damage, and other cardiovascular or renal diseases.
  • These additional factors significantly alter risk profiles beyond just blood pressure readings.
  • A comprehensive risk assessment is essential for accurate patient stratification.

Impact:

  • Enables personalized treatment strategies for hypertension.
  • Facilitates identification of high-risk patients who require more intensive interventions.
  • Optimizes the use of lifestyle modifications and antihypertensive pharmacotherapy for better patient outcomes.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...